CD8A and gastric cancer: Furthermore, whether the PD-L1 CPS was more than five or not, CD8+ T and CD8+ Tm expressing PD-1, Except PD-1+CD8+ Tn, were also significantly associated with better response and survival outcomes in advanced gastric cancer patients treated with immunotherapy plus chemotherapy.